Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiac Control Systems (CCSI) was a medical technology company that specialized in the development and manufacture of cardiac rhythm management devices, primarily pacemakers. The company was recognized for its innovative "Diamond" series of rate-responsive pacemakers, which utilized advanced sensors to adjust heart rates based on patient activity levels. Founded in the early 1980s and based in Palm Coast, Florida, CCSI operated as a publicly traded company before its acquisition by Intermedics in 1995. Its technology and product lines were subsequently integrated into the portfolios of Guidant and later Boston Scientific, contributing to the evolution of modern cardiac pacing technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiac Controls.